Article Versions Notes

Salfi G, Pedrani M, Colombo A, Ruinelli L, Brenna D, Clerici CMA, Pecoraro G, Merler S, Erhart C-C, Puglisi M, et al. Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations. Cancers. 2025; 17(23):3806. https://doi.org/10.3390/cancers17233806

Salfi, Giuseppe, Martino Pedrani, Amos Colombo, Lorenzo Ruinelli, Daniele Brenna, Chiara Maria Agrippina Clerici, Giovanna Pecoraro, Sara Merler, Caroline-Claudia Erhart, Marialuisa Puglisi, and et al. 2025. "Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations" Cancers 17, no. 23: 3806. https://doi.org/10.3390/cancers17233806

Salfi, G., Pedrani, M., Colombo, A., Ruinelli, L., Brenna, D., Clerici, C. M. A., Pecoraro, G., Merler, S., Erhart, C.-C., Puglisi, M., Turco, F., Tortola, L., Vogl, U., Gillessen, S., & Pereira Mestre, R. (2025). Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations. Cancers, 17(23), 3806. https://doi.org/10.3390/cancers17233806